PathMaker Neurosystems Announces Receipt of NIH Grant for Application of Its Non-invasive Neuromodulation Technology to Amyotrophic Lateral Sclerosis (ALS)

PathMaker Neurosystems, Inc. announced that it was awarded a Phase I STTR grant from NIH’s National Institute of Neurological Disorders and Stroke. The $371,000 award will enable the completion of key pre-clinical studies evaluating the effect of treatment with PathMaker’s breakthrough technology for motor neuron hyperexcitability suppression in transgenic ALS mice.